Clean Science and Technology Limited (BOM:543318)

India flag India · Delayed Price · Currency is INR
783.30
+3.95 (0.51%)
At close: Jun 18, 2026
Market Cap83.12B -49.5%
Revenue (ttm)9.57B -1.0%
Net Income2.30B -13.1%
EPS21.60 -13.2%
Shares Out n/a
PE Ratio36.20
Forward PE30.25
Dividend6.00 (0.77%)
Ex-Dividend DateFeb 6, 2026
Volume10,099
Open779.35
Previous Close779.35
Day's Range774.75 - 787.95
52-Week Range652.80 - 1,522.95
Betan/a
AnalystsBuy
Price Target977.50 (+24.79%)
Earnings DateAug 6, 2026

About BOM:543318

Clean Science and Technology Limited, together with its subsidiaries, manufactures fine and specialty chemicals in India, China, the Americas, Europe, and internationally. It operates through Performance Chemicals, FMCG Chemicals, and Pharmaceutical & Agro Intermediates segments. The company offers performance chemicals, including monomethyl ether of hydroquinone, butylated hydroxy anisole, tertiary butyl hydroquinone, hindered amine light stabilisers, and butylated hydroxytoluene, as well as clean antiOX 962, 4-oxo tempo, 4-butoxy tempo, clean... [Read more]

Industry Miscellaneous Chemical Products
Founded 2003
Employees 458
Stock Exchange Bombay Stock Exchange
Ticker Symbol 543318
Full Company Profile

Financial Performance

In fiscal year 2026, BOM:543318's revenue was 9.57 billion, a decrease of -1.04% compared to the previous year's 9.67 billion. Earnings were 2.30 billion, a decrease of -13.14%.

Financial Statements

Analyst Summary

According to 14 analysts, the average rating for 543318 stock is "Buy." The 12-month stock price target is ₹977.50, which is an increase of 24.79% from the latest price.

Price Target
₹977.50
(24.79% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Clean Science and Technology Transcript: Q4 25/26

Q4 FY 2026 saw sequential revenue and margin improvement, led by record HALS sales and strong export growth. Backward integration and capacity expansion are underway, while global volatility and competition remain key risks. Dividend of INR 4/share declared.

5 weeks ago - Transcripts

Clean Science and Technology Quarterly report: Q4 2026

Clean Science and Technology has published its Q4 2026 quarterly earnings report on May 14, 2026.

5 weeks ago - Filings

Clean Science and Technology Slides: Q4 2026

Clean Science and Technology has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.

5 weeks ago - Filings

Clean Science and Technology Transcript: Q3 25/26

Q3 FY26 saw revenue and margins decline due to weak demand, pricing pressure, and tariffs, but HALS business grew 55% YoY and new plants are expected to improve margins. CapEx projects are on track, and management remains focused on long-term growth despite ongoing market headwinds.

5 months ago - Transcripts

Clean Science and Technology Quarterly report: Q3 2026

Clean Science and Technology has published its Q3 2026 quarterly earnings report on January 31, 2026.

5 months ago - Filings

Clean Science and Technology Slides: Q3 2026

Clean Science and Technology has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 31, 2026.

5 months ago - Filings

Clean Science and Technology Transcript: Q2 25/26

Revenue and profit declined due to lower volumes and competitive pressures, but EBITDA margins remained robust. Health segment showed strong sequential growth, new products were commercialized, and capacity expansions are underway. Market uncertainties and tariffs continue to pose risks.

8 months ago - Transcripts

Clean Science and Technology Quarterly report: Q2 2026

Clean Science and Technology has published its Q2 2026 quarterly earnings report on November 6, 2025.

8 months ago - Filings

Clean Science and Technology Slides: Q2 2026

Clean Science and Technology has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 6, 2025.

8 months ago - Filings

Clean Science and Technology Transcript: Q1 25/26

Q1 FY26 saw resilient margins despite a 9% sequential revenue drop, with record-high standalone EBITDA margin over 46%. New product launches and CapEx investments are set to drive growth, though guidance is moderated to 15%-18% EBITDA growth for FY26.

1 year ago - Transcripts

Clean Science and Technology Quarterly report: Q1 2026

Clean Science and Technology has published its Q1 2026 quarterly earnings report on July 17, 2025.

1 year ago - Filings

Clean Science and Technology Slides: Q1 2026

Clean Science and Technology has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 17, 2025.

1 year ago - Filings